药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Levamisole
Levobupivacaine
The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Bepridil.
Levamisole
Sacubitril
The risk or severity of adverse effects can be increased when Sacubitril is combined with Bepridil.
Levamisole
Pipamperone
The risk or severity of adverse effects can be increased when Pipamperone is combined with Bepridil.
Levamisole
Nitrous acid
The risk or severity of adverse effects can be increased when Nitrous acid is combined with Bepridil.
Levamisole
Dinutuximab
The risk or severity of adverse effects can be increased when Dinutuximab is combined with Bepridil.
Levamisole
Nesiritide
The risk or severity of adverse effects can be increased when Nesiritide is combined with Bepridil.
Levamisole
Carbetocin
The risk or severity of adverse effects can be increased when Carbetocin is combined with Bepridil.
Levamisole
Diclofenamide
The risk or severity of adverse effects can be increased when Diclofenamide is combined with Bepridil.
Levamisole
Thalidomide
The risk or severity of adverse effects can be increased when Thalidomide is combined with Bepridil.
Levamisole
Encorafenib
The risk or severity of QTc prolongation can be increased when Bepridil is combined with Encorafenib.
Levamisole
Emedastine
The risk or severity of QTc prolongation can be increased when Emedastine is combined with Bepridil.
Levamisole
Pazopanib
The risk or severity of QTc prolongation can be increased when Bepridil is combined with Pazopanib.
Levamisole
Levacetylmethadol
The risk or severity of QTc prolongation can be increased when Levacetylmethadol is combined with Bepridil.
Levamisole
Ivosidenib
The risk or severity of QTc prolongation can be increased when Ivosidenib is combined with Bepridil.
Levamisole
Dexchlorpheniramine
The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine is combined with Bepridil.
Levamisole
Sultopride
The risk or severity of QTc prolongation can be increased when Sultopride is combined with Bepridil.
Levamisole
Sitafloxacin
The risk or severity of QTc prolongation can be increased when Sitafloxacin is combined with Bepridil.
Levamisole
Oxatomide
The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Bepridil.
Levamisole
Abexinostat
The risk or severity of QTc prolongation can be increased when Abexinostat is combined with Bepridil.
Levamisole
Mizolastine
The risk or severity of QTc prolongation can be increased when Mizolastine is combined with Bepridil.